Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
diphtheria toxoid + tetanus toxoid + acellular pertussis vaccine (Boryung)
- Development stage
- Unknown
- Lead developer
- Boryung Biopharma
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Boryung Biopharma's DTaP vaccine is a combination biological product developed for active immunization against diphtheria, tetanus, and pertussis (whooping cough). The vaccine contains diphtheria toxoid, tetanus toxoid, and acellular pertussis antigens as its active ingredients. Its mechanism of action involves inducing protective antibody-mediated immunity against the toxins produced by *Corynebacterium diphtheriae* and *Clostridium tetani*, as well as antigens from *Bordetella pertussis*. The vaccine has achieved approved status in South Korea and was evaluated in clinical research under the code name BVN008.
- Brand names
- DTaP Vaccine
- Other names
- DTaPdiphtheria-tetanus-acellular pertussis vaccine
02
Targets
TT (Tetanus toxoid)
Beyond the preview
Go deeper on diphtheria toxoid + tetanus toxoid + acellular pertussis vaccine (Boryung).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on diphtheria toxoid + tetanus toxoid + acellular pertussis vaccine (Boryung).